Clinical utility of HIV-IgA immunoblot assay in the early diagnosis of perinatal HIV infection.

OBJECTIVE To ascertain the sensitivity, specificity, predictive value, and clinical use of a human immunodeficiency virus (HIV)-IgA immunoblot assay for diagnosing perinatal HIV infection in infants tested at birth to 1 month, 3 months, and 6 months of age. DESIGN Prospective, longitudinal cohort study of children born to HIV-infected and noninfected women. The HIV-IgA immunoblot assays were performed at birth to 1 month, 3 months, and 6 months of age and compared with the Centers for Disease Control's classification system of HIV infection in the children. Children were followed up for at least 15 months to ensure accuracy of infection status. SETTING Municipal hospital in central Brooklyn, NY, where the prevalence of HIV infection is high. PATIENTS Serum samples from 58 children, 22 with documented HIV infection, 18 noninfected children born to seropositive women, and 18 children born to noninfected women, were studied. MAIN OUTCOME MEASURE Diagnosis of HIV infection using the Centers for Disease Control's classification scheme was compared with diagnosis using the HIV-IgA immunoblot assay for children 6 months of age or younger. RESULTS The HIV-IgA immunoblot assay yielded negative results at 3 and 6 months of age for all 18 infants born to seronegative women; for the 18 seroreverting, noninfected children born to infected women, the assay yielded negative results at 1 month, 3 months, and 6 months of age. The positive predictive value of the assay was 100%--no false-positive results were identified in the 88 serum samples obtained from noninfected infants. For the HIV-infected children, sensitivity was a function of age: one (5.9%) of 17 infants had an assay that yielded positive results at birth to 1 month of age, 13 (62%) of 21 infants had assays that yielded positive results at 3 months of age, and 17 (77%) of 22 infants had assays that yielded positive results at 6 months of age. The presence or absence of symptoms did not affect the sensitivity. CONCLUSION The HIV-IgA immunoblot assay can detect a significant proportion of infected children during an early asymptomatic period of their life. This relatively inexpensive, easily standardized assay may allow for institution of therapy before the onset of clinical symptoms.

[1]  J. Sever,et al.  Limitations in the laboratory diagnosis of vertically acquired HIV infection. , 1991, Journal of acquired immune deficiency syndromes.

[2]  L. Mofenson,et al.  Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. , 1991, The New England journal of medicine.

[3]  M. Wulfsohn,et al.  A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group. , 1991, The New England journal of medicine.

[4]  J. Church,et al.  CD4 T-lymphocyte counts and Pneumocystis carinii pneumonia in pediatric HIV infection. , 1991 .

[5]  J. Levy,et al.  Detection of infection with human immunodeficiency virus (HIV) type 1 in infants by an anti-HIV immunoglobulin A assay using recombinant proteins. , 1991, The Journal of pediatrics.

[6]  A. Ades,et al.  Children born to women with HIV-1 infection: natural history and risk of transmission , 1991, The Lancet.

[7]  Y. Bertrand,et al.  Comparison of HIV detection by virus isolation in lymphocyte cultures and molecular amplification of HIV DNA and RNA by PCR in offspring of seropositive mothers. , 1991, Journal of acquired immune deficiency syndromes.

[8]  P. Tovo,et al.  In-vitro production of HIV-1 -specific antibody for diagnosis of perinatal infection , 1990, The Lancet.

[9]  M. Moscucci,et al.  Left ventricular mass and left ventricular diastolic function , 1990, The Lancet.

[10]  R. Husson,et al.  Diagnosis of human immunodeficiency virus infection in infants and children. , 1990, Pediatrics.

[11]  E. Cooper,et al.  Early diagnosis of HIV infection in infants by detection of IgA HIV antibodies , 1990, The Lancet.

[12]  K. Mcintosh,et al.  A comparative study of virus isolation, polymerase chain reaction, and antigen detection in children of mothers infected with human immunodeficiency virus. , 1990, The Journal of pediatrics.

[13]  R. Hoff,et al.  Detection of IgM and IgA HIV antibodies after removal of IgG with recombinant protein G. , 1990, Journal of immunological methods.

[14]  C. Giaquinto,et al.  Diagnosis of human immunodeficiency virus 1 infection in infants: in vitro production of virus‐specific antibody in lymphocytes , 1990, The Pediatric Infectious Disease Journal.

[15]  John P. Johnson,et al.  Natural history and serologic diagnosis of infants born to human immunodeficiency virus-infected women. , 1989, American journal of diseases of children.

[16]  C. Czerkinsky,et al.  ELISPOT: a new approach to studying the dynamics of virus-immune system interaction for diagnosis and monitoring of HIV infection. , 1989, AIDS research and human retroviruses.

[17]  J. Levy,et al.  Polymerase chain reaction compared with concurrent viral cultures for rapid identification of human immunodeficiency virus infection among high-risk infants and children. , 1989, The Journal of pediatrics.

[18]  S. Katz,et al.  Human immunodeficiency virus infection of newborns. , 1989, New England Journal of Medicine.

[19]  W. Borkowsky,et al.  Human immunodeficiency virus type 1 antigenemia in children. , 1989, The Journal of pediatrics.

[20]  H. Ochs,et al.  Perinatal infection with human immunodeficiency virus. Specific antibody responses by the neonate. , 1987, The New England journal of medicine.

[21]  C. Giaquinto,et al.  INFANTS BORN TO MOTHERS SEROPOSITIVE FOR HUMAN IMMUNODEFICIENCY VIRUS Preliminary Findings from a Multicentre European Study , 1987, The Lancet.